Improved method for estimation of azole antifungal inhibitory concentrations against Candida species, based on azole/antibiotic interactions
- PMID: 3746584
- DOI: 10.1080/02681218680000461
Improved method for estimation of azole antifungal inhibitory concentrations against Candida species, based on azole/antibiotic interactions
Abstract
Low, reproducible minimal inhibitory concentrations against Candida species, with sharp, precise end points in complex media were achieved for imidazoles (clotrimazole, econazole, miconazole, tioconazole and ketoconazole) and triazoles (fluconazole, itraconazole, vibunazole, ICI 153066) by including in the test medium antibacterial antibiotics that bind to the 80S eukaryotic ribosome and inhibit protein synthesis, i.e. blasticidin, cycloheximide, doxycycline, neomycin and gentamicin. The presence of these antibiotics reduced MICs, on average, by 50- to 250-fold. Other protein synthesis inhibitors (rifampicin, erythromycin, lincomycin, clindamycin, chloramphenicol and fusidic acid) were not effective, and the antibiotics did not affect MICs for Aspergillus species. The low azole MICs were in close agreement with MICs obtained in a defined, tissue culture-based medium lacking added antibiotics.
Similar articles
-
Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.J Antimicrob Chemother. 1984 Aug;14(2):105-14. doi: 10.1093/jac/14.2.105. J Antimicrob Chemother. 1984. PMID: 6094418
-
In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata.J Med Microbiol. 1999 Jul;48(7):663-670. doi: 10.1099/00222615-48-7-663. J Med Microbiol. 1999. PMID: 10403417
-
Candida glabrata: in vitro susceptibility of 84 isolates to eight antifungal agents.Chemotherapy. 1996 Mar-Apr;42(2):107-11. doi: 10.1159/000239429. Chemotherapy. 1996. PMID: 8697885
-
Overview of medically important antifungal azole derivatives.Clin Microbiol Rev. 1988 Apr;1(2):187-217. doi: 10.1128/CMR.1.2.187. Clin Microbiol Rev. 1988. PMID: 3069196 Free PMC article. Review.
-
Resistance of yeasts to azole-derivative antifungals.J Antimicrob Chemother. 1993 Apr;31(4):463-71. doi: 10.1093/jac/31.4.463. J Antimicrob Chemother. 1993. PMID: 8514644 Review.
Cited by
-
Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans.Antimicrob Agents Chemother. 2000 Sep;44(9):2373-81. doi: 10.1128/AAC.44.9.2373-2381.2000. Antimicrob Agents Chemother. 2000. PMID: 10952582 Free PMC article.
-
Comparative efficacy of amphotericin B, clotrimazole and itraconazole against Aspergillus spp. An in vitro study.Mycopathologia. 1993 Sep;123(3):135-40. doi: 10.1007/BF01111263. Mycopathologia. 1993. PMID: 8302362
-
Collaborative evaluation in seven laboratories of a standardized micromethod for yeast susceptibility testing.J Clin Microbiol. 1988 Nov;26(11):2307-12. doi: 10.1128/jcm.26.11.2307-2312.1988. J Clin Microbiol. 1988. PMID: 3235657 Free PMC article.
-
Oral Candida in Patients with Fixed Orthodontic Appliance: In Vitro Combination Therapy.Biomed Res Int. 2017;2017:1802875. doi: 10.1155/2017/1802875. Epub 2017 Jun 8. Biomed Res Int. 2017. PMID: 28685145 Free PMC article. Clinical Trial.
-
Tetracycline alters drug susceptibility in Candida albicans and other pathogenic fungi.Microbiology (Reading). 2008 Mar;154(Pt 3):960-970. doi: 10.1099/mic.0.2007/013805-0. Microbiology (Reading). 2008. PMID: 18310042 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical